Global Wearable Injectors Market to Reach US$ 24.4 Billion by 2032, Spurred by the Increasing Prevalence of Chronic Medical Illnesses

September 30, 2022 | Healthcare

The latest report by IMARC Group, titled “Wearable Injectors Market Report by Type (On-body, Off-body), Technology (Spring-based, Motor-driven, Rotary Pump, Expanding Battery, and Others), Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, and Others), End Use (Hospitals and Clinics, Home Care, and Others), and Region 2024-2032,” finds that the global wearable injectors market size reached US$ 7.7 Billion in 2023. Wearable injectors (WIs) or patch pumps are drug delivery devices utilized for the single-step administration of medicines for longer durations. They automatically deliver preset doses to patients at optimal times. They are temporarily attached to the skin to deliver viscous drugs in large volumes faster and safely through the subcutaneous tissues in the body. They comprise a cannula for substance delivery to tissues, a reservoir to store medicine, and a drive system to provide the appropriate drug volume. In addition, these devices are user-friendly, disposable, and cause minimal discomfort and pain compared to traditionally used syringes and vials. As a result, wearable injectors are extensively used for the treatment of diabetes, rheumatoid arthritis, cancer, and cardiovascular diseases.

Global Wearable Injectors Market Trends:

The market is primarily driven by the increasing prevalence of chronic medical illnesses such as neurological, oncological, and autoimmune disorders. In addition, the rising geriatric population, which is more susceptible to such ailments, and the escalating demand for minimally invasive (MI) treatment alternatives among the patients represent other major growth-inducing factors. Moreover, the sudden outbreak of the coronavirus disease (COVID-19) pandemic prompted the entire healthcare system to switch to home-based therapies to stop the spread of the sickness. This, coupled with the growing popularity of at-home and self-administrable injectors to effectively manage disorders with the minutest risks of inaccurate dosage and needle stick injuries, is providing a positive thrust to the market growth. Besides this, various product innovations, such as the incorporation of wireless connectivity, passive warning systems, and Bluetooth technologies with the injectors, are anticipated to propel the market growth. These technologies promote convenient monitoring of the patient through a smartphone application and offer timely reminders for dosages. Furthermore, extensive research and development (R&D) activities, along with significant improvements in the healthcare infrastructure, are creating a positive market outlook. Looking forward, IMARC Group expects the market value to reach US$ 24.4 Billion by 2032, exhibiting a CAGR of 13.4% during the forecast period (2024-2032).

Market Summary:

  • Based on the type, the market has been bifurcated into on-body and off-body.
  • On the basis of technology, the market has been classified into spring-based, motor-driven, rotary pump, expanding battery, and others.
  • Based on the application, the market has been segmented into oncology, infectious diseases, cardiovascular diseases, autoimmune diseases, and others.
  • On the basis of the end use, the market has been divided into hospitals and clinics, home care, and others.
  • Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the industry has also been examined in the report, with some of the key players being Becton Dickinson and Company, CeQur SA, Debiotech SA, Dexcom Inc., Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Tandem Diabetes Care Inc., West Pharmaceutical Services Inc. and Ypsomed AG.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Type, Technology, Application, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Becton Dickinson and Company, CeQur SA, Debiotech SA, Dexcom Inc., Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Tandem Diabetes Care Inc., West Pharmaceutical Services Inc. and Ypsomed AG
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Wearable Injectors Market to Reach US$ 24.4 Billion by 2032, Spurred by the Increasing Prevalence of Chronic Medical Illnesses
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More